{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:42:43Z","timestamp":1792759363303,"version":"4.5.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pan.2026.10.025","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:26:50Z","timestamp":1792481210000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunctions in pancreatic ductal adenocarcinoma: Pathogenic mechanisms and therapeutic implications"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5491-0770","authenticated-orcid":false,"given":"R\u00faben","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-5541","authenticated-orcid":false,"given":"Raquel","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7801-4643","authenticated-orcid":false,"given":"M. Helena","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-1917","authenticated-orcid":false,"given":"Cristina P.R.","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib2","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pan.2026.10.025_bib3","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"43","key":"10.1016\/j.pan.2026.10.025_bib4","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.pan.2026.10.025_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bpg.2017.09.015","article-title":"Do smoking and alcohol behaviours influence GI cancer survival?","volume":"31","author":"McMenamin","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/MPA.0000000000000162","article-title":"The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus","volume":"43","author":"Gardner","year":"2014","journal-title":"Pancreas"},{"issue":"8","key":"10.1016\/j.pan.2026.10.025_bib7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.cgh.2019.11.043","article-title":"New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population","volume":"18","author":"Huang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.pan.2026.10.025_bib8","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.ebiom.2015.11.023","article-title":"Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses","volume":"2","author":"Samokhvalov","year":"2015","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib9","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.15171\/mejdd.2017.65","article-title":"Menstrual and reproductive factors and risk of pancreatic cancer in women","volume":"9","author":"Masoudi","year":"2017","journal-title":"Middle East J Dig Dis"},{"issue":"12","key":"10.1016\/j.pan.2026.10.025_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/aje\/kws458","article-title":"ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis","volume":"177","author":"Risch","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pan.2026.10.025_bib12","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.12659\/MSM.913769","article-title":"ABO Blood Group and diabetes mellitus Influence the risk for pancreatic cancer in a population from China","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pan.2026.10.025_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/VHRM.S9252","article-title":"Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)","volume":"6","author":"Ciccone","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.pan.2026.10.025_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yasu.2010.05.011","article-title":"Update on familial pancreatic cancer","volume":"44","author":"Hruban","year":"2010","journal-title":"Adv Surg"},{"issue":"34","key":"10.1016\/j.pan.2026.10.025_bib15","doi-asserted-by":"crossref","first-page":"12118","DOI":"10.3748\/wjg.v20.i34.12118","article-title":"Early detection and prevention of pancreatic cancer: is it really possible today?","volume":"20","author":"Del Chiaro","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","article-title":"Tobacco and the risk of pancreatic cancer: a review and meta-analysis","volume":"393","author":"Iodice","year":"2008","journal-title":"Langenbecks Arch Surg"},{"issue":"5","key":"10.1016\/j.pan.2026.10.025_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1055-9965.EPI-19-1027","article-title":"Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships","volume":"29","author":"Molina-Montes","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1055-9965.EPI-08-0880","article-title":"Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies","volume":"18","author":"Genkinger","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pan.2026.10.025_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12885-016-2241-1","article-title":"Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pan.2026.10.025_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2017.10.007","article-title":"KRAS, YAP, and obesity in pancreatic cancer: a signaling network with multiple loops","volume":"54","author":"Eibl","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"22","key":"10.1016\/j.pan.2026.10.025_bib21","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/onc.2016.461","article-title":"Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53","volume":"36","author":"Swidnicka-Siergiejko","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.canlet.2016.07.022","article-title":"Modifiable and non-modifiable risk factors for pancreatic cancer: a review","volume":"381","author":"Midha","year":"2016","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12913-017-2345-6","article-title":"Surgeons' knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study","volume":"17","author":"Li","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.pan.2026.10.025_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820962117","article-title":"Pancreatic cancer: a review of risk factors, diagnosis, and treatment","volume":"19","author":"Zhao","year":"2020","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PPO.0b013e31827459b6","article-title":"Pathology and molecular genetics of pancreatic neoplasms","volume":"18","author":"Wood","year":"2012","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.seminoncol.2014.12.002","article-title":"Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma","volume":"42","author":"Yeo","year":"2015","journal-title":"Semin Oncol"},{"issue":"32","key":"10.1016\/j.pan.2026.10.025_bib27","doi-asserted-by":"crossref","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","article-title":"Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection","volume":"20","author":"Becker","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41467-018-02942-5","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer","volume":"9","author":"Klein","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.pan.2026.10.025_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","article-title":"Epidemiology of pancreatic cancer: an overview","volume":"6","author":"Raimondi","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.21037\/cco.2017.12.04","article-title":"Inherited pancreatic cancer","volume":"6","author":"Chen","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.pan.2026.10.025_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2018.09.008","article-title":"Metabolism and epigenetics of pancreatic cancer stem cells","volume":"57","author":"Perusina","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.gastro.2018.05.041","article-title":"Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1","volume":"155","author":"Nimmakayala","year":"2018","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib33","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acschembio.0c00219","article-title":"Impact of extracellular fatty acids and oxygen tension on lipid synthesis and assembly in pancreatic cancer cells","volume":"15","author":"Downes","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.pan.2026.10.025_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101594","article-title":"Disruption of adipocyte YAP improves glucose homeostasis in mice and decreases adipose tissue fibrosis","volume":"66","author":"Han","year":"2022","journal-title":"Mol Metab"},{"issue":"324","key":"10.1016\/j.pan.2026.10.025_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005049","article-title":"Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci Signal"},{"issue":"Supplement_1","key":"10.1016\/j.pan.2026.10.025_bib36","doi-asserted-by":"crossref","DOI":"10.2337\/db23-308-OR","article-title":"308-OR: hippo-yap\/taz signaling coordinates adipose plasticity and energy balance by Uncoupling Leptin Expression from fat mass","volume":"72","author":"Choi","year":"2023","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib37","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pan.2026.10.025_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.trsl.2016.07.017","article-title":"Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state","volume":"179","author":"Djuric","year":"2017","journal-title":"Transl Res"},{"issue":"10","key":"10.1016\/j.pan.2026.10.025_bib39","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mdu276","article-title":"Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium","volume":"25","author":"Bosetti","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endrev\/bnab037","article-title":"A modern approach to dyslipidemia","volume":"43","author":"Berberich","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12986-016-0119-5","article-title":"Fatty acids stimulate insulin secretion from human pancreatic islets at fasting glucose concentrations via mitochondria-dependent and -independent mechanisms","volume":"13","author":"Cen","year":"2016","journal-title":"Nutr Metab"},{"key":"10.1016\/j.pan.2026.10.025_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/DMSO.S115855","article-title":"Diabetes and dyslipidemia: characterizing lipoprotein metabolism","volume":"10","author":"Tomkin","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib43","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1016\/S0021-9258(18)42624-5","article-title":"Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion","volume":"267","author":"Prentki","year":"1992","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI117042","article-title":"Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle","volume":"93","author":"Zhou","year":"1994","journal-title":"J Clin Investig"},{"issue":"15","key":"10.1016\/j.pan.2026.10.025_bib45","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-09-4615","article-title":"Fructose induces transketolase flux to promote pancreatic cancer growth","volume":"70","author":"Liu","year":"2010","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s11695-008-9599-3","article-title":"Obesity, pancreatitis, and pancreatic cancer","volume":"18","author":"Gumbs","year":"2008","journal-title":"Obes Surg"},{"issue":"8","key":"10.1016\/j.pan.2026.10.025_bib47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.286.8.921","article-title":"Physical activity, obesity, height, and the risk of pancreatic cancer","volume":"286","author":"Michaud","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pan.2026.10.025_bib48","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","article-title":"Obesity-Induced inflammation and Desmoplasia promote pancreatic cancer progression and resistance to chemotherapy","volume":"6","author":"Incio","year":"2016","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2014.5","article-title":"Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma","volume":"5","author":"Hori","year":"2014","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.surg.2009.02.024","article-title":"Obesity potentiates the growth and dissemination of pancreatic cancer","volume":"146","author":"Zyromski","year":"2009","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pharmthera.2013.01.008","article-title":"Adipocytes: impact on tumor growth and potential sites for therapeutic intervention","volume":"138","author":"Hefetz-Sela","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","article-title":"The clinical significance of pancreatic steatosis","volume":"8","author":"Smits","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2026.10.025_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fonc.2013.00282","article-title":"Risk factors and therapeutic targets in pancreatic cancer","volume":"3","author":"W\u00f6rmann","year":"2013","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.pan.2026.10.025_bib54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pan.2026.10.025_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12416","article-title":"Obesity and cancer pathogenesis","volume":"1311","author":"Berger","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5662\/wjm.v6.i1.43","article-title":"Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer","volume":"6","author":"Lipsey","year":"2016","journal-title":"World J Methodol"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9090122","article-title":"EMT and treatment resistance in pancreatic cancer","volume":"9","author":"Gaianigo","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"26","key":"10.1016\/j.pan.2026.10.025_bib58","doi-asserted-by":"crossref","first-page":"18239","DOI":"10.18632\/oncotarget.24435","article-title":"Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer","volume":"9","author":"Harbuzariu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2026.10.025_bib59","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v8.i2.106","article-title":"Leptin signaling and cancer chemoresistance: perspectives","author":"Candelaria","year":"2017","journal-title":"World J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.pan.2026.10.025_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113331","article-title":"Pancreatic cancer and obesity: molecular mechanisms of cell transformation and chemoresistance","volume":"19","author":"Cascetta","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pan.2026.10.025_bib62","article-title":"The roles of adipose tissue macrophages in human disease","author":"Liang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.pan.2026.10.025_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/life14070856","article-title":"The interplay between obesity and inflammation","author":"Savulescu-Fiedler","year":"2024","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib64","article-title":"The role of notch signaling and Leptin-Notch crosstalk in pancreatic cancer","volume":"5","author":"Harbuzariu","year":"2018","journal-title":"Medicines (Basel)"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib65","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.cellsig.2010.05.003","article-title":"Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB\/HIF-1alpha activation","volume":"22","author":"Gonzalez-Perez","year":"2010","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib66","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1158\/0008-5472.CAN-08-4312","article-title":"Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/ERC-12-0329","article-title":"IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression","volume":"20","author":"Ford","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib68","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1940-6207.CAPR-12-0034","article-title":"Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models","volume":"5","author":"Dunlap","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","article-title":"Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study","volume":"67","author":"Fan","year":"2018","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib70","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.18632\/oncotarget.3109","article-title":"Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Maisonneuve","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.pan.2026.10.025_bib72","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrclinonc.2013.169","article-title":"Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates","volume":"10","author":"Gronich","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib73","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/ol.2017.5572","article-title":"Statins and pancreatic cancer","volume":"13","author":"Gong","year":"2017","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.pan.2026.10.025_bib74","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.metabol.2011.03.005","article-title":"Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis","volume":"60","author":"Rosato","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.pan.2026.10.025_bib75","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fphys.2014.00426","article-title":"Diabetes, pancreatic cancer, and metformin therapy","volume":"5","author":"Gong","year":"2014","journal-title":"Front Physiol"},{"issue":"10","key":"10.1016\/j.pan.2026.10.025_bib76","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1572-0241.2008.02051.x","article-title":"Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies","volume":"103","author":"Bonovas","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib77","first-page":"1099","article-title":"Statin use and risk of pancreatic cancer: a meta-analysis","volume":"23","author":"Cui","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pan.2024.11.010","article-title":"High prevalence of pancreatic steatosis in pancreatic cancer patients: a meta-analysis and systematic review","volume":"25","author":"Vl\u0103du\u021b","year":"2025","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jgh3.12032","article-title":"Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: a single-center experience","volume":"2","author":"Lesmana","year":"2018","journal-title":"JGH Open"},{"key":"10.1016\/j.pan.2026.10.025_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib81","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/MPA.0000000000000159","article-title":"Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma","volume":"43","author":"Tomita","year":"2014","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-021-00551-0","article-title":"Intra-pancreatic fat deposition: bringing hidden fat to the fore","volume":"19","author":"Petrov","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.pan.2026.10.025_bib83","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/MPA.0b013e318220e742","article-title":"Enhancement of carcinogenesis and fatty infiltration in the pancreas in N-nitrosobis(2-oxopropyl)amine-treated hamsters by high-fat diet","volume":"40","author":"Hori","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2026.10.025_bib84","author":"Townsend"},{"key":"10.1016\/j.pan.2026.10.025_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2011.4","article-title":"The clinical significance of pancreatic steatosis","author":"Smits","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2026.10.025_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-021-00573-3","article-title":"Metabolic implications of pancreatic fat accumulation","author":"Wagner","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib87","doi-asserted-by":"crossref","DOI":"10.1590\/s0004-2803.202000000-27","article-title":"Pancreatic steatosis: a new diagnosis and therapeutic challenge in gastroenterology","volume":"57","author":"Paul","year":"2020","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.pan.2026.10.025_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103996","article-title":"Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer","author":"Truong","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pan.2026.10.025_bib89","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002625","article-title":"Bidirectional association between non-alcoholic fatty liver disease and fatty pancreas: a systematic review and meta-analysis","author":"Wongtrakul","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2026.10.025_bib90","doi-asserted-by":"crossref","DOI":"10.14218\/JCTH.2022.00085","article-title":"Fatty pancreas: linking pancreas pathophysiology to Nonalcoholic Fatty liver disease","author":"Rugivarodom","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"7354","key":"10.1016\/j.pan.2026.10.025_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"Denicola","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/mc.20778","article-title":"Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms","volume":"51","author":"Bracci","year":"2012","journal-title":"Mol Carcinog"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.06.056","article-title":"NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer","volume":"166","author":"Chio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pan.2026.10.025_bib94","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.110.225698","article-title":"Endoplasmic reticulum stress and inflammation in obesity and diabetes","author":"Hummasti","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.pan.2026.10.025_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic Reticulum stress and the inflammatory basis of metabolic disease","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pan.2026.10.025_bib96","article-title":"The role of the nrf2 signaling in obesity and insulin resistance","author":"Li","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pan.2026.10.025_bib97","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2021.08.006","article-title":"Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells","volume":"174","author":"Grattarola","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pan.2026.10.025_bib98","article-title":"Role of nrf2 in pancreatic cancer","author":"Cykowiak","year":"2022","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib99","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12456","article-title":"dCK negatively regulates the NRF2\/ARE axis and ROS production in pancreatic cancer","volume":"51","author":"Hu","year":"2018","journal-title":"Cell Prolif"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib100","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ije\/dyv001","article-title":"Metabolic risk score and cancer risk: pooled analysis of seven cohorts","volume":"44","author":"Stocks","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.pan.2026.10.025_bib101","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.cgh.2014.02.032","article-title":"Can we prevent pancreatic disease?","volume":"12","author":"Lowenfels","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.pan.2026.10.025_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111408","article-title":"Simvastatin attenuated tumor growth in different pancreatic tumor animal models","volume":"15","author":"Chen","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"19","key":"10.1016\/j.pan.2026.10.025_bib103","article-title":"Statin use and its impact on survival in pancreatic cancer patients","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.pan.2026.10.025_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2020.01.008","article-title":"Statin use improves survival in patients with pancreatic ductal adenocarcinoma: a meta-analysis","author":"Tamburrino","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.pan.2026.10.025_bib105","doi-asserted-by":"crossref","DOI":"10.21037\/tcr.2020.01.27","article-title":"Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling","volume":"9","author":"Cai","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib106","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MPA.0b013e318030e963","article-title":"Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans","volume":"34","author":"Khurana","year":"2007","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.pan.2026.10.025_bib107","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1007\/s10620-013-2778-7","article-title":"The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom","volume":"58","author":"Carey","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.pan.2026.10.025_bib108","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/cncr.29256","article-title":"Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib109","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11605-011-1448-3","article-title":"Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer","volume":"15","author":"Chagpar","year":"2011","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MPA.0b013e31825de678","article-title":"Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients","volume":"42","author":"Nakai","year":"2013","journal-title":"Pancreas"},{"issue":"19_Supplement","key":"10.1016\/j.pan.2026.10.025_bib111","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1158\/1538-7445.AM2014-2173","article-title":"Abstract 2173: survival time in pancreatic cancer patients with metabolic syndrome varies by use of insulin and statins","volume":"74","author":"Jeon","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2026.10.025_bib112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1476-511X-12-126","article-title":"The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells","volume":"12","author":"Gbelcov\u00e1","year":"2013","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib113","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1349-7006.2009.01475.x","article-title":"The role of oxysterol binding protein-related protein 5 in pancreatic cancer","volume":"101","author":"Ishikawa","year":"2010","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib114","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bjc.2014.385","article-title":"Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation","volume":"111","author":"Souchek","year":"2014","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib115","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.freeradbiomed.2011.06.008","article-title":"Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway","volume":"51","author":"Shin-Kang","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.pan.2026.10.025_bib116","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1073\/pnas.1421601112","article-title":"Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma","volume":"112","author":"Guillaumond","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.pan.2026.10.025_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028813","article-title":"Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites","volume":"6","author":"Menter","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib118","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/ijc.23242","article-title":"Differences in antitumor effects of various statins on human pancreatic cancer","volume":"122","author":"Gbelcov\u00e1","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-013-2328-1","article-title":"Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients","volume":"73","author":"Hong","year":"2014","journal-title":"Cancer Chemother Pharmacol 20131027th ed"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib120","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3748\/wjg.v20.i9.2279","article-title":"Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer","volume":"20","author":"Swierczynski","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2 Pt A","key":"10.1016\/j.pan.2026.10.025_bib121","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2014.03.028","article-title":"Epidemiological-molecular evidence of metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer","volume":"356","author":"S\u00f8reide","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pan.2026.10.025_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2013.49","article-title":"New insights into pancreatic cancer-induced paraneoplastic diabetes","author":"Sah","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib123","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.01.039","article-title":"Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus","volume":"134","author":"Pannala","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2026.10.025_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(08)70337-1","article-title":"New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer","author":"Pannala","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pan.2026.10.025_bib125","doi-asserted-by":"crossref","DOI":"10.2337\/db16-1477","article-title":"Diabetes, pancreatogenic diabetes, and pancreatic cancer","author":"Andersen","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib126","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000584","article-title":"Prevalence of new-onset diabetes in patients undergoing pancreatic surgery and the Association of glucose dysregulation with complications in pancreatic cancer","volume":"6","author":"Stott","year":"2025","journal-title":"Ann Surg Open"},{"issue":"9","key":"10.1016\/j.pan.2026.10.025_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70878","article-title":"Assessing NODM patients for early PDAC diagnosis: incidence of NODM before PDAC diagnosis and subsequent PDAC risk","volume":"14","author":"Munigala","year":"2025","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.pan.2026.10.025_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.pan.2026.10.025_bib129","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2012-0302","article-title":"Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis","volume":"18","author":"Bosetti","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.pan.2026.10.025_bib130","article-title":"Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies","author":"Colmers","year":"2012","journal-title":"Diabetes Metabol"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2011.483","article-title":"Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis","volume":"107","author":"Bodmer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2026.10.025_bib132","article-title":"Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.pan.2026.10.025_bib133","doi-asserted-by":"crossref","DOI":"10.1007\/s13300-016-0198-3","article-title":"Incretin-Based therapy and risk of pancreatic cancer in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"7","author":"Chen","year":"2016","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.pan.2026.10.025_bib134","doi-asserted-by":"crossref","DOI":"10.2337\/dc17-0280","article-title":"Incretin-Based therapies and the short-term risk of pancreatic cancer: results from two retrospective cohort studies","author":"Boniol","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2016.10.003","article-title":"Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: a population-based study in Taiwan","volume":"17","author":"Tseng","year":"2017","journal-title":"Pancreatology"},{"issue":"7506","key":"10.1016\/j.pan.2026.10.025_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pan.2026.10.025_bib137","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-017-0701-0","article-title":"Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer","volume":"16","author":"Chen","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.pan.2026.10.025_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2014.04.007","article-title":"Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","author":"Wang","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.pan.2026.10.025_bib139","article-title":"Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis","volume":"28","author":"Hu","year":"2017","journal-title":"Biomed Res"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib140","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000000590","article-title":"Weight loss, diabetes, fatigue, and depression preceding pancreatic cancer","volume":"45","author":"Olson","year":"2016","journal-title":"Pancreas"},{"issue":"15","key":"10.1016\/j.pan.2026.10.025_bib141","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.15692","article-title":"Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and metaanalysis","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"37","key":"10.1016\/j.pan.2026.10.025_bib142","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17728","article-title":"Prognostic significance of anti-diabetic medications in pancreatic cancer: a meta-analysis","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2026.10.025_bib143","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2017.1541","article-title":"Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: a meta-analysis","author":"Xin","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.pan.2026.10.025_bib144","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.4129","article-title":"Metformin use and pancreatic cancer survival in U.S. veterans with diabetes mellitus: are there racial differences?","volume":"37","author":"Toriola","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pan.2026.10.025_bib145","article-title":"Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in Korea","volume":"8","author":"Jang","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.pan.2026.10.025_bib146","article-title":"No association between metformin use and survival in patients with pancreatic cancer","volume":"96","author":"Frouws","year":"2017","journal-title":"Medicine (United States)"},{"issue":"16","key":"10.1016\/j.pan.2026.10.025_bib147","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.63.3511","article-title":"Metformin use and survival of patients with pancreatic cancer: a cautionary lesson","volume":"34","author":"Chaiteerakij","year":"2016","journal-title":"J Clin Oncol"},{"issue":"30","key":"10.1016\/j.pan.2026.10.025_bib148","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1511698112","article-title":"Functional expression of sodium-glucose transporters in cancer","volume":"112","author":"Scafoglio","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.pan.2026.10.025_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25189932","article-title":"Effect of sodium-glucose Co-Transporter 2 inhibitors combined with metformin on pancreatic cancer cell lines","volume":"25","author":"Cristov\u00e3o","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pan.2026.10.025_bib150","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-1722","article-title":"(Ir)relevance of metformin treatment in patients with metastatic pancreatic cancer: an open-label, randomized phase II trial","volume":"22","author":"Reni","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.pan.2026.10.025_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)00027-3","article-title":"Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial","volume":"16","author":"Kordes","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326015590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326015590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:56:57Z","timestamp":1792756617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390326015590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":151,"alternative-id":["S1424390326015590"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2026.10.025","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunctions in pancreatic ductal adenocarcinoma: Pathogenic mechanisms and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2026.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}